HeartFlow, Inc. (HTFL): Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Official company branding of HeartFlow, Inc. (HTFL)

Heartflow Inc generates revenue through high-margin SaaS subscriptions for cloud-based AI blood flow analysis. The EV/EBITDA trajectory reflects the business valuation dynamics, with the latest value recorded as 0.00. The digital architecture enables seamless scaling of remote diagnostics, while growth in the B2B segment remains independent of broader economic conditions, relying primarily on the expansion of health insurance programs.

HTFL (HeartFlow Medical) Enterprise Value to Operating Income Before Depreciation Ratio history from 11/23/2025 to 11/10/2026
Original product of HeartFlow Inc

Fundamental asset selection is based on comparing Enterprise Value (EV) with EBITDA, which allows for the valuation of a company without the influence of debt load or tax regimes. This calculation is critically important for Heartflow Inc (HTFL) as it scales its AI platform and integrates into US insurance standards, a fact clearly reflected in the company's historical EV/EBITDA trend.

Competitors of Heartflow Inc (HTFL)

EV/EBITDA Multiple REGN (Regeneron Inc.)|EV/EBITDA Multiple iRhythm Corp IRTC|LNTH - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation MLYS (mineralystx.com)|KMTS (Kestra Medical) - Enterprise Value to EBITDA Ratio|ESPR: Enterprise Value to Operating Income Before Depreciation Ratio|AMRN (Amarin Corp) - EV/EBITDA Multiple|Anteris Technologies Ltd - Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tenaya Therapeutics (TNYA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CVRX (cvrx.com)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Milestone Pharmaceuticals Inc. MIST|Cardiol Therapeutics Inc (CRDL) - Company Value to EBITDA|BEAT: Enterprise Value to EBITDA Ratio|Tenax Therapeutics Inc (TENX) - Enterprise Value to EBITDA Ratio|ADGM (Adagio Medical Holdings) - Enterprise Value to EBITDA Ratio|biocardia.com - Business Value to Operating Income Before Depreciation|VTAK (Catheter Precision, Inc.) - EV/EBITDA Multiple|ARCA Bio (ABIO) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Acasti Pharma (ACST)|Aerovate Therapeutics, Inc - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple VERV (Verve Therapeutics, Inc.)|WINT - Enterprise Value to EBITDA Ratio